FCCC LOGO Faculty Publications
Naing A , Cohen R , Dy GK , Hong DS , Dyster L , Hangauer DG , Kwan R , Fetterly G , Kurzrock R , Adjei AA
A phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies
Investigational New Drugs. 2013 Aug;31(4) :967-973
PMID: WOS:000322333600018   
Back to previous list
Abstract
Notes
Naing, Aung Cohen, Roger Dy, Grace K. Hong, David S. Dyster, Lyn Hangauer, David G. Kwan, Rudolf Fetterly, Gerald Kurzrock, Razelle Adjei, Alex A.